SENNA

Product NDC: 71399-8237
11-digit product format: 713998237
Labeler code: 71399
Product ID: 71399-8237_a95e938e-ed52-4328-b339-2c0b63a66b03
Type: HUMAN OTC DRUG
Nonproprietary name: SENNA
Dosage form: SYRUP
Route: ORAL
Labeler: Akron Pharma Inc.
Application: part334
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2019-10-25
Marketing end: 0000-00-00
Substance: SENNOSIDES A AND B
Active strength: 417 mg/237mL
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	71399-8237		I	Inactivated by FDA		2026-10-12
excluded package	package	71399-8237	71399-8237-8	I	Inactivated by FDA		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	71399-8237-8	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	71399-8237-8	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71399-8237-8	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71399-8237-8	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71399-8237-8	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71399-8237-8	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71399-8237-8	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71399-8237-8	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71399-8237-8	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
71399-8237-8	2025-01-30	C162847	48780-1	f386c64a-47dd-0266-e053-dadaa90a7c1a	SENNA SYRUP Natural Vegitable Lexative
71399-8237-8	2023-03-26	C162847	48780-1	f386c64a-47dd-0266-e053-dadaa90a7c1a	SENNA SYRUP Natural Vegitable Lexative
71399-8237-8	2023-01-30	C162847	48780-1	f386c64a-47dd-0266-e053-dadaa90a7c1a	SENNA SYRUP Natural Vegitable Lexative

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
71399-8237-8	SENNA	237 mL in 1 BOTTLE	SYRUP	237		3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71399-8237	SENNA SYRUP [AKRON PHARMA INC.]	3	Legacy NDC, 1 package rows	20230327_9e9c434a-7075-45d4-b7b3-0f83a33cf046.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
1B5FPI42EN	SENNOSIDES A AND B	62211-03-4	SENNOSIDES A AND B

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
702311	sennosides 8.8 MG in 5 mL Oral Solution	PSN	8b7cc0d5-029b-43f7-a050-8771e7db4551	4
702311	sennosides, USP 1.76 MG/ML Oral Solution	SCD	8b7cc0d5-029b-43f7-a050-8771e7db4551	4
702311	sennosides 8.8 MG per 5 mL Oral Syrup	SY	8b7cc0d5-029b-43f7-a050-8771e7db4551	4
702311	sennosides, USP 26.4 MG per 15 ML Oral Solution	SY	8b7cc0d5-029b-43f7-a050-8771e7db4551	4
702311	sennosides, USP 8.8 MG per 5 ML Oral Solution	SY	8b7cc0d5-029b-43f7-a050-8771e7db4551	4
702311	sennosides 8.8 MG in 5 mL Oral Solution	PSN	9e9c434a-7075-45d4-b7b3-0f83a33cf046	3
702311	sennosides, USP 1.76 MG/ML Oral Solution	SCD	9e9c434a-7075-45d4-b7b3-0f83a33cf046	3
702311	sennosides 8.8 MG per 5 mL Oral Syrup	SY	9e9c434a-7075-45d4-b7b3-0f83a33cf046	3
702311	sennosides, USP 26.4 MG per 15 ML Oral Solution	SY	9e9c434a-7075-45d4-b7b3-0f83a33cf046	3
702311	sennosides, USP 8.8 MG per 5 ML Oral Solution	SY	9e9c434a-7075-45d4-b7b3-0f83a33cf046	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
71399-8237-8	71399823708	237 mL in 1 BOTTLE (71399-8237-8)	237 ml	2019-10-25	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
SENNA SYRUP Natural Vegitable Lexative	ATLANTIC BIOLOGICALS CORP. \| UNIT DOSE SOLUTIONS	2025-07-31	HUMAN OTC DRUG LABEL	4
SENNA SYRUP Natural Vegitable Lexative	Akron Pharma Inc.	2023-03-18	HUMAN OTC DRUG LABEL	3